Power source selection for a fully implantable LVAD system

Patent metadata

Field	Value
Publication number	US-11452860-B2
Application number	US-202016944564-A
Country	US
Kind code	B2
Filing date	Jul 31, 2020
Priority date	Jul 31, 2020
Publication date	Sep 27, 2022
Grant date	Sep 27, 2022

Abstract

A method of managing multiple power sources for an implantable blood pump includes operating the implantable blood pump with both power from an internal battery, the internal battery being disposed within an implantable controller and in communication with the implantable blood pump, and with transcutaneous energy transfer system (TETS) power in communication with the implantable blood pump, if TETS power is available.

First claim

What is claimed is:

1. A method of managing multiple power sources for an implantable blood pump, comprising:
operating the implantable blood pump with both power from an internal battery and transcutaneous energy transfer system (TETS) power simultaneously, the internal battery being disposed within an implantable controller and in communication with the implantable blood pump, and the TETS in communication with the implantable blood pump.

2. The method of claim 1 , further including subsequently switching the implantable blood pump to operate with only TETS power if:
a set speed of the implantable blood pump is able to be maintained by TETS power alone and an internal battery capacity is greater than a predetermined reserve threshold.

3. The method of claim 1 , further including subsequently switching the implantable blood pump to operate with only TETS power if:
a minimum speed of the implantable blood pump is able to be maintained by TETS power alone and an internal battery capacity is less than a predetermined reserve threshold.

4. The method of claim 1 , further including subsequently switching the implantable blood pump to operate with only TETS power if power from the internal battery is unavailable.

5. The method of claim 1 , further including subsequently switching the implantable blood pump to operate only with power from the internal battery if TETS power is unavailable.

6. The method of claim 1 , further including subsequently switching the implantable blood pump to operate only with power from the internal battery if a battery learning cycle is required and all the prerequisites for the battery learning cycle are met.

7. A method of managing multiple power sources for an implantable blood pump, comprising:
operating the implantable blood pump with both power from an internal battery and transcutaneous energy transfer system (TETS) power simultaneously, the internal battery being disposed within an implantable controller and in communication with the implantable blood pump, and the TETS in communication with the implantable blood pump, if during operation of the implantable blood pump:
a minimum speed of the implantable blood pump is unable to be maintained by TETS power alone and an internal battery capacity is less than a predetermined reserve threshold; or
a set speed of the implantable blood pump is unable to be maintained by TETS power alone and the internal battery capacity is greater than the predetermined reserve threshold.

8. The method of claim 7 , further including subsequently switching the implantable blood pump to operate with only TETS power if power from the internal battery is unavailable.

9. The method of claim 7 , further including subsequently switching the implantable blood pump to operate only with power from the internal battery if TETS power is unavailable.

10. The method of claim 7 , further including subsequently switching the implantable blood pump to operate only with power from the internal battery if a battery learning cycle is required and all the prerequisites for the battery learning cycle are met.

11. A control circuit for an implantable blood pump, comprising:
processing circuitry configured to:
operate the implantable blood pump with both power from an internal battery and transcutaneous energy transfer system (TETS) power simultaneously, the internal battery being disposed within an implantable controller and in communication with the implantable blood pump, and the TETS in communication with the implantable blood pump, if TETS power is available and if battery only operation is not required.

12. The control circuit of claim 11 , wherein the processing circuitry is further configured to subsequently switch the implantable blood pump to operate with only TETS power if:
a set speed of the implantable blood pump is able to be maintained by TETS power alone and an internal battery capacity is greater than a predetermined reserve threshold.

13. The control circuit of claim 11 , wherein the processing circuitry is further configured to subsequently switch the implantable blood pump to operate with only TETS power if:
a minimum speed of the implantable blood pump is able to be maintained by TETS power alone and an internal battery capacity is less than a predetermined reserve threshold.

14. The control circuit of claim 11 , wherein the processing circuitry is further configured to subsequently switch the implantable blood pump to operate only with TETS power if power from the internal battery is unavailable.

15. The control circuit of claim 11 , wherein the processing circuitry is further configured to subsequently switch the implantable blood pump to operate only with power from the internal battery if TETS power is unavailable.

16. The control circuit of claim 11 , wherein the processing circuitry is further configured to subsequently switch the implantable blood pump to operate only with power from the internal battery if a battery learning cycle is required and all the prerequisites for the battery learning cycle are met.

17. A control circuit for an implantable blood pump, comprising:
processing circuitry configured to:
operate the implantable blood pump with both power from an internal battery and transcutaneous energy transfer system (TETS) power simultaneously, the internal battery being disposed within an implantable controller and in communication with the implantable blood pump, and the TETS in communication with the implantable blood pump, if during operation of the implantable blood pump:
a minimum speed of the implantable blood pump is unable to be maintained by TETS power alone and an internal battery capacity is less than a predetermined reserve threshold; or
a set speed of the implantable blood pump is unable to be maintained by TETS power alone and the internal battery capacity is greater than the predetermined reserve threshold.

18. The control circuit of claim 17 , wherein the processing circuitry is further configured to subsequently switch the implantable blood pump to operate with only TETS power if power from the internal battery is unavailable.

19. The control circuit of claim 17 , wherein the processing circuitry is further configured to subsequently switch the implantable blood pump to operate only with power from the internal battery if TETS power is unavailable.

20. The control circuit of claim 17 , wherein the processing circuitry is further configured to subsequently switch the implantable blood pump to operate only with power from the internal battery if a battery learning cycle is required and all the prerequisites for the battery learning cycle are met.

Assignees

• Medtronic Inc

Inventors

• Schilling Eric A
• Roe Jacob A
• Artmann Joel B
• Lee Jason C
• Roberts Jonathan P
• Peichel David J

Classifications

• A61M2205/3365

  Rotational speed · CPC title

• A61M60/873

  specially adapted for wireless or transcutaneous energy transfer [TET], e.g. inductive charging · CPC title

• A61M2205/52

  with memories providing a history of measured variating parameters of apparatus or patient · CPC title

• A61M60/178 Primary

  drawing blood from a ventricle and returning the blood to the arterial system via a cannula external to the ventricle, e.g. left or right ventricular assist devices · CPC title

• A61M2205/8206

  battery-operated · CPC title